Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 1115418 BOSTON, MA
Back to PHAT Full portfolio

Position in PHAT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$654,754
+$38,827 QoQ
Shares Held
60,346
+8.9% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 161 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 18% Shared 0% None 82%

Common Shares in PHAT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. PHAT ranks #161 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in PHAT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $654,754 60,346
2026-03-31 $615,927 55,439
2025-12-31 $864,222 52,093
2025-09-30 $726,362 61,713
2025-06-30 $619,101 64,557
2025-03-31 $355,753 56,739
2024-12-31 $454,460 55,968
2024-09-30 $919,512 50,858
2024-06-30 $568,333 55,178
2024-03-31 $500,233 47,103
2023-12-31 $442,823 48,502
2023-09-30 $586,288 56,537
2023-06-30 $718,935 50,205
2023-03-31 $233,913 32,761
2022-12-31 $344,813 30,732
2022-09-30 $320,511 28,927
2022-06-30 $224,917 26,649
2022-03-31 $271,764 19,968
2021-12-31 $338,461 17,207
2021-09-30 $560,273 17,454
2021-06-30 $556,426 16,438
2021-03-31 $427,808 11,390
2020-12-31 $405,284 12,200
2020-09-30 $400,436 10,920
2020-06-30 $420,918 12,790
2020-03-31 $294,941 11,423